DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 200 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,404,518 | -55.8% | 407,393 | -36.8% | 0.00% | -50.0% |
| Q2 2023 | $19,031,412 | +44.2% | 644,914 | +12.6% | 0.00% | +33.3% |
| Q1 2023 | $13,198,303 | -38.5% | 572,843 | -25.7% | 0.00% | -40.0% |
| Q4 2022 | $21,454,080 | -4.0% | 771,452 | +5.9% | 0.01% | 0.0% |
| Q3 2022 | $22,352,000 | +80.5% | 728,272 | +73.1% | 0.01% | +66.7% |
| Q2 2022 | $12,382,000 | -5.3% | 420,742 | +3.6% | 0.00% | 0.0% |
| Q1 2022 | $13,069,000 | -28.7% | 406,228 | -1.1% | 0.00% | -25.0% |
| Q4 2021 | $18,320,000 | -65.6% | 410,764 | -61.1% | 0.00% | -63.6% |
| Q3 2021 | $53,304,000 | +10.0% | 1,056,558 | +71.0% | 0.01% | 0.0% |
| Q2 2021 | $48,461,000 | +31.0% | 617,818 | -4.6% | 0.01% | +22.2% |
| Q1 2021 | $36,992,000 | -37.1% | 647,851 | -7.8% | 0.01% | -40.0% |
| Q4 2020 | $58,833,000 | +224.8% | 702,394 | +38.9% | 0.02% | +200.0% |
| Q3 2020 | $18,113,000 | +228.8% | 505,542 | +121.9% | 0.01% | +150.0% |
| Q2 2020 | $5,509,000 | +139.5% | 227,809 | +73.4% | 0.00% | +100.0% |
| Q1 2020 | $2,300,000 | +31.0% | 131,365 | +30.3% | 0.00% | – |
| Q4 2019 | $1,756,000 | +10.1% | 100,787 | -3.2% | 0.00% | – |
| Q3 2019 | $1,595,000 | -20.0% | 104,087 | +8.4% | 0.00% | -100.0% |
| Q2 2019 | $1,994,000 | -20.0% | 96,058 | -10.5% | 0.00% | 0.0% |
| Q1 2019 | $2,491,000 | +76.5% | 107,294 | +57.1% | 0.00% | – |
| Q4 2018 | $1,411,000 | +432.5% | 68,278 | +460.7% | 0.00% | – |
| Q3 2018 | $265,000 | -67.5% | 12,178 | -77.3% | 0.00% | – |
| Q2 2018 | $816,000 | -68.7% | 53,530 | -59.6% | 0.00% | -100.0% |
| Q1 2018 | $2,610,000 | +19.2% | 132,535 | -5.3% | 0.00% | 0.0% |
| Q4 2017 | $2,189,000 | – | 139,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |